UKCapital Intelligence Plans
← Funding directory

Dated funding evidence

Enara Bio

Series B · $32.5M · 2024-10-01

Reported round$32.5MSeries B
Disclosure date
2024-10-01
Reported currency
USD
Companies House
10469748
Evidence sources
2

Company

Enara BioCH 10469748
2024-10-01Series B$32.5M

Resolved investor records

Pfizer VenturesLead investorM VenturesLead investorRA CapitalInvestorSamsara BioCapitalInvestorSV Health InvestorsInvestorThe Francis Crick InstituteInvestor

Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.

SourceVC research snapshot; Live Chris T D1Date2024-10-01Matchfunding_id joined to resolved canonical companyStatepublished

Record fields

What the source states

Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.

Round ID
FR-00211
Stage
Series B
Round name
Series B
Amount
$32.5M
Lead investors
Pfizer Ventures, M Ventures
Other investors
RA Capital, Samsara BioCapital, SV Health Investors, The Francis Crick Institute
Source layers
VC research snapshot, Live Chris T D1
Snapshot
2026-08-25

Named evidence

Source trail

This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.